|
onthoudingsverschijnselen van ruxolitinib (aandoening)
onthoudingsverschijnselen van ruxolitinib
abstinentiesyndroom van ruxolitinib
Ruxolitinib withdrawal
Ruxolitinib withdrawal syndrome
Ruxolitinib discontinuation syndrome
RDS - ruxolitinib discontinuation syndrome
A characteristic ruxolitinib discontinuation syndrome includes an acute relapse of disease symptoms, splenomegaly, and occasional hemodynamic decompensation. Symptoms can appear from less than 24 hours to up to 3 weeks after the abrupt discontinuation of ruxolitinib.
Id1220658004
StatusDefined
SNOMED CT to ICD-10 extended map
TargetF19.3
RuleTRUE
AdviceALWAYS F19.3
CorrelationSNOMED CT source code to target map code correlation not specified